Specifications

Specifications:

Sensitivity and Specificity

− COVID-19 – Sensitivity 93.9%, Specificity 100%

− Flu A – Sensitivity 91.4%, Specificity 95.7%

− Flu B – Sensitivity 87.6%, Specificity 95.9%

• FDA Emergency Use Authorization (EUA)
• Visually read in 15 minutes
• Flocked nasopharyngeal swab for superior specimen collection and patient comfort